Curis, Inc. (CRIS) Reports Fourth Quarter And Year-End 2013 Financial Results
2/20/2014 8:46:49 AM
LEXINGTON, Mass., Feb. 20, 2014 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), an oncology-focused company developing novel, targeted drug candidates for the treatment of human cancers, today reported its financial results for the fourth quarter and year ended December 31, 2013.
Help employers find you! Check out all the jobs and post your resume.
comments powered by